Journals / Erciyes Üniversitesi Fen Bilimleri Enstitüsü Fen Bilimleri Dergisi / 2022 / Cilt: 38 - Sayı: 2

Predicting Liver Disease Using Decision Tree Ensemble Methods

Pages
261–267
Publication Date
2022-08-23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The most successful classification result was obtained with the Light GBM algorithm as 98.8%, 98.1%, 99.4%, and 0.98%, respectively, in terms of accuracy, precision, recall, and kappa statistics using 10-fold cross-validation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Damages that may occur in the liver, which has an important task for the human body, can cause fatal consequences.
📊
Key Findings & Data:In this context, Random Forest (RF), J48, AdaBoost, Gradient Boosting Classifiers (GBC), and Light Gradient Boosting Machine (Light GBM) algorithms from bagging and boosting models were used.
💡
Conclusion & Impact:The most successful classification result was obtained with the Light GBM algorithm as 98.8%, 98.1%, 99.4%, and 0.98%, respectively, in terms of accuracy, precision, recall, and kappa statistics using 10-fold cross-validation.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Liver Disease · Classification · Ensemble learning

Özet

Damages that may occur in the liver, which has an important task for the human body, can cause fatal consequences. For this reason, early diagnosis of liver disease is important. In this study, liver disease was tried to be diagnosed by using Ensemble learning methods, depending on several clinical values obtained from liver patients and healthy blood donors. In this context, Random Forest (RF), J48, AdaBoost, Gradient Boosting Classifiers (GBC), and Light Gradient Boosting Machine (Light GBM) algorithms from bagging and boosting models were used. The most successful classification result was obtained with the Light GBM algorithm as 98.8%, 98.1%, 99.4%, and 0.98%, respectively, in terms of accuracy, precision, recall, and kappa statistics using 10-fold cross-validation.

🔖

Cite This Article

ORHANBULUCU, F., ACER, İ., LATİFOĞLU, F., İÇER, S. (2022). Predicting Liver Disease Using Decision Tree Ensemble Methods. Erciyes Üniversitesi Fen Bilimleri Enstitüsü Fen Bilimleri Dergisi, Cilt: 38 - Sayı: 2, 261–267. https://ajindex.com/articles/662982

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. World Health Organization (WHO), 2020. Hepatitis C Key Facts. https://www.who.int/newsroom/fact-sheets/detail/hepatitis-c (Accessed: September. 10, 2021)
  2. Hauri, A. M., Armstrong, G. L., & Hutin, Y. J. 2004. The global burden of disease attributable to contaminated injections given in health care settings. International journal of STD & AIDS, 15(1),pp.7-16
  3. Khatun, M., & Ray, R. B. (2019). Mechanisms underlying hepatitis C virus-associated hepatic fibrosis. Cells, 8(10), 1249
  4. Suk, K. T., & Kim, D. J. 2015. Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement. World journal of hepatology, 7(3), 607
  5. Akkaya, O., Kiyici, M., Yilmaz, Y., Ulukaya, E., & Yerci, O. 2007. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World journal of gastroenterology: WJG, 13(41), 5481
  6. Pradat, P., Alberti, A., Poynard, T., Esteban, J. I., Weiland, O. et al. 2002. Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study. Hepatology, 36(4), pp.973-977
  7. Awan, S. E., Bennamoun, M., Sohel, F., Sanfilippo, F. M., & Dwivedi, G. 2019. Machine learning‐based prediction of heart failure readmission or death: implications of choosing the right model and the right metrics. ESC heart failure, 6(2), pp.428-435
  8. Oladimeji, O. O., Oladimeji, A., Olayanju, O. 2021. Machine Learning Models for Diagnostic Classification of Hepatitis C Tests. Frontiers in Health Informatics, 10(1), 70
  9. Orooji, A., Kermani, F. 2021. Machine learning based methods for handling imbalanced data in hepatitis diagnosis. Frontiers in Health Informatics, 10(1), 57
  10. Mostafa, F. B., Hasan, E. 2021. Machine Learning Approaches for Binary Classification to Discover Liver Diseases using Clinical Data. medRxiv
  11. Gupta, S., Gupta, M. K. 2021. A comprehensive data‐level investigation of cancer diagnosis on imbalanced data. Computational Intelligence
  12. Hoffmann, G., Bietenbeck, A., Lichtinghagen, R., Klawonn, F. 2018. Using machine learning techniques to generate laboratory diagnostic pathways—a case study. J Lab Precis Med, 3, 58
  13. Dua, D., Graff, C. 2019. UCI Machine Learning Repository Irvine, CA: University of California, School of Information and Computer Science. http://archive.ics.uci.edu/ml. (Accessed: April, 26, 2021)
  14. Chawla, N. V., Bowyer, K. W., Hall, L. O., Kegelmeyer, W. P. 2002. SMOTE: synthetic minority over-sampling technique